Otamixaban

From Self-sufficiency

Revision as of 17:20, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Otamixaban
Systematic (IUPAC) name
File:Otamixaban.svg
File:Otamixaban 3D.png
methyl (2R,3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate
Identifiers
CAS Number	193153-04-7
ATC code	none
PubChem	CID 5496659
Chemical data
Formula	C₂₅H₂₆N₄O₄
Molar mass	446.498 g/mol[[Script error: No such module "String".]]

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Otamixaban (INN) is an inhibitor of Factor Xa,^[1] currently being developed by the French pharmaceutical company Sanofi-Aventis as a treatment for acute coronary syndrome.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

Glycoprotein IIb/IIIa inhibitors	Abciximab • Eptifibatide • Tirofiban
ADP receptor/P2Y₁₂ inhibitors	thienopyridines (Clopidogrel, Prasugrel, Ticlopidine) • Ticagrelor^†
Prostaglandin analogue (PGI2)	Beraprost • Prostacyclin • Iloprost • Treprostinil
COX inhibitors	Acetylsalicylic acid/Aspirin^# • Aloxiprin • Carbasalate calcium • Indobufen • Triflusal
Thromboxane inhibitors	thromboxane synthase inhibitors (Dipyridamole, Picotamide) • receptor antagonist (Terutroban^†)
Phosphodiesterase inhibitors	Cilostazol • Dipyridamole • Triflusal
Other	Cloricromen • Ditazole

Factor Xa inhibitors
(with some II inhibition)

Heparin group/ glycosaminoglycans/ (bind antithrombin)	low molecular weight heparin (Bemiparin, Certoparin, Dalteparin, Enoxaparin, Nadroparin, Parnaparin, Reviparin, Tinzaparin) oligosaccharides (Fondaparinux, Idraparinux) heparinoid (Danaparoid, Sulodexide, Dermatan sulfate)
Direct Xa inhibitors	xabans (Apixaban, Betrixaban, Edoxaban, Otamixaban, Rivaroxaban)